Cascade Investment Advisors Inc. Makes New $1.50 Million Investment in Zoetis Inc. $ZTS

Cascade Investment Advisors Inc. acquired a new position in shares of Zoetis Inc. (NYSE:ZTS) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 11,915 shares of the company’s stock, valued at approximately $1,499,000.

Several other hedge funds have also modified their holdings of ZTS. Summit Place Financial Advisors LLC grew its stake in Zoetis by 0.4% during the 3rd quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock worth $2,834,000 after purchasing an additional 76 shares in the last quarter. First County Bank CT boosted its stake in shares of Zoetis by 5.4% in the 3rd quarter. First County Bank CT now owns 1,535 shares of the company’s stock valued at $225,000 after buying an additional 79 shares during the period. CWA Asset Management Group LLC grew its position in shares of Zoetis by 1.1% during the third quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after buying an additional 80 shares in the last quarter. Balefire LLC grew its position in shares of Zoetis by 3.5% during the third quarter. Balefire LLC now owns 2,463 shares of the company’s stock worth $360,000 after buying an additional 84 shares in the last quarter. Finally, Evergreen Capital Management LLC increased its stake in shares of Zoetis by 3.3% during the third quarter. Evergreen Capital Management LLC now owns 2,696 shares of the company’s stock worth $394,000 after buying an additional 85 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several analyst reports. William Blair reaffirmed an “outperform” rating on shares of Zoetis in a report on Monday, March 2nd. UBS Group set a $136.00 price target on shares of Zoetis in a report on Thursday, January 29th. BTIG Research reissued a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a research report on Thursday, February 26th. Piper Sandler restated a “neutral” rating and issued a $135.00 price objective (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Finally, Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research report on Thursday, December 18th. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $152.91.

Zoetis Stock Performance

Shares of ZTS opened at $113.48 on Friday. The company has a market capitalization of $47.90 billion, a price-to-earnings ratio of 18.85, a price-to-earnings-growth ratio of 1.73 and a beta of 0.95. Zoetis Inc. has a 52-week low of $113.29 and a 52-week high of $172.23. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. The stock has a 50 day moving average price of $123.39 and a 200 day moving average price of $129.17.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The company had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.36 billion. During the same quarter last year, the company earned $1.40 earnings per share. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Research analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio is presently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.